Zobrazeno 1 - 10
of 4 273
pro vyhledávání: '"Chronic Schizophrenia"'
Publikováno v:
Industrial Psychiatry Journal, Vol 33, Iss Suppl 1, Pp S64-S71 (2024)
Background: A large proportion of persons with schizophrenia are either abandoned by their family members in mental hospitals or do not have any family members to look after them. Therefore, almost 2/3rd of hospital beds are occupied by chronic schiz
Externí odkaz:
https://doaj.org/article/50d301b9accd4737bcfa60c2640e6e8b
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background To explore the influence of CYP2D6 genetic polymorphism on risperidone metabolism, thereby affecting risperidone’s effects and safeties in patients with chronic schizophrenia. Methods Sixty-nine subjects with chronic schizophren
Externí odkaz:
https://doaj.org/article/a51254b408744958902d3a8ab1663df5
Autor:
Yin Xia Bai, Jia Xin Luo, Duo Peng, Jing Jing Sun, Yi Fang Gao, Li Xia Hao, B. G. Tong, Xue Mei He, Jia Yu Luo, Zi Hong Liang, Fan Yang
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
IntroductionChronic schizophrenia has a course of 5 years or more and has a widespread abnormalities in brain functional connectivity. This study aimed to find characteristic functional and structural changes in a long illness duration chronic schizo
Externí odkaz:
https://doaj.org/article/9463e9f2c5d74635b77f3e8bf7186844
Autor:
Teng-Hung Yu, Thung-Lip Lee, Chin-Feng Hsuan, Cheng-Ching Wu, Chao-Ping Wang, Yung-Chuan Lu, Ching-Ting Wei, Fu-Mei Chung, Yau-Jiunn Lee, I-Ting Tsai, Wei-Hua Tang
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2024)
IntroductionOf all psychiatric disorders, schizophrenia is associated with the highest risk of all-cause mortality. This study aimed to investigate independent risk factors for all-cause mortality in patients with chronic schizophrenia. In addition,
Externí odkaz:
https://doaj.org/article/8dd231e6e0714e9097df4ff79a09cb81
Autor:
L. N. Gorobets, I. V. Dorovskikh, A. V. Litvinov, V. S. Bulanov, S. K. Gamdullaev, T. A. Pavlova
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 57, Iss 3, Pp 48-58 (2023)
Introduction. Although scientific literature demonstrates a relationship between prolactin levels, the efficacy of aripiprazole therapy, and negative symptoms in patients with schizophrenia, many questions regarding these problems remain controversia
Externí odkaz:
https://doaj.org/article/68654a85b2034e1f978eda1d33881d98
Autor:
Yue Zhou, Xingzhi Xia, Xueli Zhao, Ruchang Yang, Yuxuan Wu, Junjun Liu, Xiaoli Lyu, Zhe Li, Guangya Zhang, Xiangdong Du
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Objective Previous studies have shown that transcranial direct current stimulation(tDCS) led to an improvement of cognitive function in patients with schizophrenia, but rare study has explored the effect of tDCS on long-term hospitalized chr
Externí odkaz:
https://doaj.org/article/847226634f4a4a10a44b887e40616944
Publikováno v:
Sichuan jingshen weisheng, Vol 36, Iss 3, Pp 254-258 (2023)
BackgroundThe improvement of social function in patients with schizophrenia is an important part of their rehabilitation， and peer support services， as a rehabilitation method， may be of great significance to improve the social function of pati
Externí odkaz:
https://doaj.org/article/0629db90bd5a40478bd6ce7fd0a6bdae
Publikováno v:
Chinese Medicine, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Background Based on the neuroinflammation hypothesis in schizophrenia and known anti-inflammatory effects of berberine, the aim of the present study is to investigate the efficacy of berberine in treating negative symptoms and cognitive defi
Externí odkaz:
https://doaj.org/article/8dedfd98f566419aa4d4f6fce47733b1
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
IntroductionPharmacological treatment may be effective for treating positive symptoms of schizophrenia; no evidence of clinically significant effects on negative and cognitive symptoms, social and behavioral functioning. This review investigated trea
Externí odkaz:
https://doaj.org/article/493563db207c4f98a60c1e50948016f7
Autor:
Abeer Mamdouh Ali Mahmoud, Mai Abd-Elraoof Eissa, Enaas Ahmad Kolkaila, Reham Abdel Rahman Amer, Mona Ahmed Kotait
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 59, Iss 1, Pp 1-13 (2023)
Abstract Background Due to its disturbance in schizophrenic patients, mismatch negativity (MMN) generation is believed to be a potential biomarker for recognizing primary impairments in auditory sensory processing during the course of the disease. Ho
Externí odkaz:
https://doaj.org/article/8b37fac2875944a1a54639fcd3dcb5b6